von Redaktion LCGC | Juli 15, 2012
Early palliative care for patients with metastatic cancer Gaertner J, Wolf J, Voltz R Journal: Current Opinion in Oncology, Vol 24, No 4, July 2012, doi:10.1097/CCO.0b013e328352ea20Veröffentlichung: Juli...
von Redaktion LCGC | Juli 15, 2012
Predictive value of early and late 18F-fluorodeoxyglucose and 18F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib Kobe C, Scheffler M, Holstein A, Zander T, Nogovam L, Lammertsma AA, Boellaard...
von Redaktion LCGC | Juli 1, 2012
Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non–Small Cell Lung Cancer Treated With Erlotinib Kahraman D, Holstein A, Scheffler, M, Zander T, Nogova L, Lammertsma, A, Boellaard...
von Redaktion LCGC | Mai 15, 2012
Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities Perez-Moreno P, Brambilla E, Thomas RK, Soria JC Journal: Clinical Cancer Research, Vol 18, No 9, May 2012 May, doi: 10.1158/1078-0432.CCR-11-2370Veröffentlichung: Mai...
von Redaktion LCGC | März 15, 2012
Recommending early integration of palliative care – does it work? Gaertner J, Wolf J, Frechen S, Klein U, Scheicht D, Hellmich M, Toepelt K, Glossmann JP, Ostgathe C, Hallek M, Voltz R Journal: Support Care Cancer, Vol 20, No 3, March 2012, doi:...
